April 17th Options Now Available For Rivian Automotive (RIVN)

Rivian (RIVN) is the subject of two options trade ideas: selling the $11 put (bid $0.33) would obligate purchase at $11 with an effective cost basis of $10.67 versus the current stock price of $14.47, is ~24% OTM, carries an 82% chance of expiring worthless and yields 3.00% (15.22% annualized) if it does. On the call side, selling the $16 covered call (bid $0.92) against shares bought at $14.47 would cap sale at $16 (~11% OTM) with a 49% chance of expiring worthless and offers a 16.93% total return if called (premium equals a 6.36% boost or 32.25% annualized). Implied volatility is 87% for the put and 103% for the call versus a trailing 12‑month realized volatility of 58%; StockOptionsChannel will track contract odds and histories on its site.

Analysis

Market structure: The current option setup benefits premium sellers and patient buyers willing to take assignment — selling the Apr17 $11 put nets $0.33 (3.0% on $1,100 cash) with an 82% modeled chance of expiring worthless, while covered-call sellers at $16 can lock ~16.9% to expiry. EV suppliers (batteries, chips) and Amazon (RIVN strategic partner/customer) have more convex exposure to production surprises; incumbent automakers gain pricing power if EV demand stalls. Elevated implied vols (87% put, 103% call vs 58% realized) signal demand for hedging/speculation rather than a clean supply shock.

Risk assessment: Immediate horizon (days-weeks) is dominated by option expiries (Apr17) and short-term IV moves; medium-term (quarters) by deliveries, production ramp, and any capital raises; long-term (2-3 years) by path to positive FCF and fleet revenue (Amazon vans). Tail risks: Amazon contract modification, catastrophic recall, or a dilutive cash raise could wipe >50% of equity value; rising rates amplify financing risk. Hidden dependencies include RIVN’s manufacturing cadence, single large customer concentration, and dealer/direct sales execution.

Trade implications: Favor premium selling strategies size-constrained: cash-secured puts at $11 (target 1–2% portfolio, close if stock < $9.50 or IV rises >30% from entry) or covered calls at $16 for existing stockholders to harvest 16.9% to Apr17. Use defined-risk spreads (sell $11 / buy $8) to cap assignment downside and sell short-dated call credit spreads ($16/$18) to harvest elevated call IV; avoid buying short-dated calls given IV > realized. Consider a small long-dated LEAP (12–18 months) only if RIVN hits delivery/FCF milestones.

Contrarian angles: The market may be mispricing asymmetric outcomes — IV > realized suggests premium-rich environment where sellers have the edge absent a catalyst. Consensus underestimates the optionality of an Amazon-led fleet scale; conversely, it understates dilution risk if deliveries miss. Historical parallel: early unprofitable EVs that survived had multi-year institutional support; failure modes often came from execution + capital shortfall, not demand alone. Watch-for unintended crowding in put-selling that could amplify moves on bad news.

Key Decisions for Investors

• Sell cash-secured RIVN Apr17 $11 puts (collect $0.33) sized to 1–2% of portfolio value per contract (cash commitment $1,100 each); set automatic close if RIVN < $9.50 or if IV on the put rises >30% from entry (protects vs skew blowout).
• If assigned/own RIVN, sell Apr17 $16 covered calls to lock ~16.9% gross to expiry; position size total long equity at 1–3% portfolio and roll/close if stock >$16 or if IV compresses >20% (capture gains).
• Use defined-risk put spreads as a downside-limited alternative: sell Apr17 $11 / buy Apr17 $8 to cap assignment at $8; size these at 50% of cash-secured put allocation to limit capital at risk.
• Harvest elevated call IV via short 30–60 day call credit spreads (e.g., sell $16 / buy $18) sized 0.5–1% portfolio, close on IV compression >15 points or stock gap >15% against spread.
• Allocate 0.5–1% portfolio to a conditional long LEAP (12–18 month $15–$20 calls) only after two consecutive monthly delivery beats or a confirmed non-dilutive financing announcement; otherwise avoid long-dated outright buys given high implied vol and capital risk.